Is Botox FSA or HSA Eligible? The Cosmetic Carve-Out and the Letter of Medical Necessity

Botox is the most widely performed minimally invasive cosmetic procedure in the United States, with millions of patients receiving injections annually to soften forehead lines, frown lines, and crow's feet. As out-of-pocket healthcare expenses rise, a common financial question emerges: Can you pay for Botox treatments using a Flexible Spending Account (FSA) or a Health Savings Account (HSA)?

The short answer is no for cosmetic treatments, but yes for medically necessary therapeutic treatments.

Under the Internal Revenue Service (IRS) tax code, there is a strict boundary between elective cosmetic enhancement and medically necessary therapeutic care. (If you are still weighing the base cost of treatment, our Botox cost planning guide breaks down per-unit versus per-area pricing before any tax considerations.) This article provides a comprehensive regulatory and clinical guide to navigating Botox FSA/HSA eligibility. We examine the IRS rules under Publication 502, analyze the unique FDA brand split of botulinum toxin under Biologics License Application (BLA) 103000, detail the specific medical conditions that qualify for tax-free reimbursement, outline how plan administrators audit these claims, and provide a step-by-step checklist and template for obtaining a tax-compliant Letter of Medical Necessity (LMN).

---

The IRS Medical Expense Standard: IRC Section 213(d) and Publication 502

To understand why some Botox injections can be reimbursed while others cannot, we must look at the statutory definition of a medical expense. Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are governed by Section 213(d) of the Internal Revenue Code (IRC).

The Cosmetic Carve-Out

IRC Section 213(d)(9) explicitly excludes cosmetic surgery and other similar procedures from the definition of deductible medical care. The tax code defines cosmetic surgery as:

"...any procedure which is directed at improving the patient’s appearance and does not meaningfully promote the proper function of the body or prevent or treat illness or disease."

The IRS enforces this rule strictly in IRS Publication 502 (Medical and Dental Expenses). Under the section titled "Cosmetic Surgery," the IRS states that you cannot include in medical expenses the cost of elective cosmetic procedures. This includes face-lifts, hair transplants, liposuction, and injections of dermal fillers or botulinum toxins when performed solely to reduce wrinkles or signs of aging.

The Deformity Exception

There is a narrow statutory exception to the cosmetic carve-out. A cosmetic procedure can be considered deductible medical care if it is necessary to correct or improve a deformity arising from, or directly related to:

• A congenital abnormality (a birth defect).
• A personal injury resulting from an accident or trauma.
• A disfiguring disease (e.g., reconstructive surgery following breast cancer treatment).

Because standard cosmetic Botox injections for forehead lines or crow's feet do not correct a physical deformity caused by trauma, birth defects, or disfiguring disease, they are locked out of FSA/HSA reimbursement. Attempting to pay for cosmetic treatments with these funds is a violation of the tax code.

---

FDA Approvals: The Biological Licensing Split (BLA 103000)

One of the most fascinating aspects of botulinum toxin regulation in the United States is how the FDA and the manufacturer, AbbVie (formerly Allergan), structured the product's regulatory approval. This structure mirrors the IRS's distinction between medical and cosmetic use.

Under the FDA's Biologics License Application (BLA) database, specifically BLA 103000, the FDA maintains two distinct brand registrations for the exact same active biological substance (OnabotulinumtoxinA):

1. BOTOX: Cleared for therapeutic indications, including chronic migraine, severe primary axillary hyperhidrosis, detrusor overactivity (overactive bladder), cervical dystonia, blepharospasm, and upper limb spasticity.
2. BOTOX COSMETIC: Cleared specifically for aesthetic indications, including the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines), lateral canthal lines (crow's feet), and forehead lines.

The Clinical and Marketing Partition

While the liquid inside the vials is chemically identical, the packaging, marketing, billing codes, and FDA-approved labeling are separated.

This partition is a crucial compliance indicator for FSA/HSA plan administrators. When a patient submits a receipt for a treatment labeled "Botox Cosmetic," administrators immediately flag it for denial because the product brand itself is cleared exclusively for aesthetic use. For a tax-exempt claim to be substantiated, the clinical documentation must reference the therapeutic "Botox" brand associated with a specific, non-cosmetic medical diagnosis.

---

HSA vs. FSA Accounts: Mechanics of Auditing and Substantiation

Flexible Spending Accounts (FSAs) and Health Savings Accounts (HSAs) share similar tax advantages, but their auditing and substantiation mechanisms differ significantly:

FSA Claims: Pre-Substantiation Audits

FSA plans are typically front-funded by employers, and the plans are subject to strict Department of Labor and IRS compliance rules.

• FSA Card Declines: If you swipe an FSA card at an aesthetic clinic or a medical spa, the transaction will often be declined immediately. This is because the merchant category code (MCC) for the business is registered under "7298" (Cosmetic/Beauty Shops) or "8099" (Medical Services - Not Elsewhere Classified) rather than a standard medical doctor's office or pharmacy.
• Manual Substantiation: To get an FSA claim approved, you must submit manual documentation. The plan administrator reviews this documentation before verifying the expense. If you cannot provide an itemized receipt showing medical coding and a signed Letter of Medical Necessity (LMN), the funds will not be released, or you will be forced to repay the card transaction out of pocket.

HSA Claims: Post-Audit Responsibility

HSA funds are owned entirely by the individual, and the money rolls over year-to-year.

• No Immediate Declines: HSA card transactions are rarely declined at the point of sale, as there is no immediate pre-substantiation process.
• The IRS Audit Risk: The individual is responsible for ensuring that all distributions from their HSA are for qualified medical expenses. If the IRS audits your tax return, you must produce itemized receipts, diagnostic codes, and Letters of Medical Necessity for every dollar spent.
• Penalties: If the IRS determines you used HSA funds for unqualified cosmetic expenses, the distributed amount will be added to your taxable income for that year. Furthermore, you will face an additional 20% tax penalty on the unqualified distribution (unless you are age 65 or older).

---

Clinical Indications: When Botox Qualifies as a Therapeutic Expense

For botulinum toxin injections to qualify as a tax-exempt medical expense under IRC Section 213(d), a physician must diagnose the patient with a recognized clinical condition. The three most common indications where Botox crosses this boundary are detailed below.

1. Chronic Migraine

Botox was approved by the FDA in 2010 for the prevention of headaches in adult patients with chronic migraine.

• Clinical Definition: The FDA defines chronic migraine as having 15 or more headache days per month, with each headache lasting 4 hours or more, for at least 3 months. Botox is not cleared or eligible for patients with episodic migraines (14 or fewer headache days per month).
• Treatment Protocol: The standard clinical protocol (PREEMPT paradigm) involves injecting a total of 155 units of Botox across 31 specific injection sites in seven key muscle groups of the head and neck (including the forehead, temples, back of the head, and upper shoulders).
• CPT Medical Coding: To substantiate a claim, the provider's invoice must use the appropriate Current Procedural Terminology (CPT) code:
  • CPT 64615: Chemodenervation of muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (for chronic migraine).
  • ICD-10 Diagnostic Code: Must include a code such as G43.709 (Chronic migraine without aura, not intractable, without status migrainosus).

2. Severe Primary Axillary Hyperhidrosis

Primary axillary hyperhidrosis is a medical condition characterized by excessive, uncontrollable underarm sweating that is unrelated to body temperature or physical exertion. (Our clinical guide to Botox for hyperhidrosis covers the treatment protocol in depth; this section focuses on the reimbursement and coding rules.)

• Clinical Definition: The condition must significantly interfere with the patient's daily activities (e.g., needing to change clothes multiple times per day, skin maceration) and must be unresponsive to clinical-strength topical antiperspirants (such as 20% aluminum chloride).
• Treatment Protocol: Typically involves injecting 50 units of Botox per underarm (100 units total), distributed in a grid pattern across the areas of maximum sweat production.
• CPT Medical Coding:
  • CPT 64650: Chemodenervation of eccrine glands; axillae.
  • ICD-10 Diagnostic Code: Must include L74.510 (Primary focal hyperhidrosis, axilla).

3. Temporomandibular Joint (TMJ) Dysfunction and Masseter Hypertrophy

Temporomandibular joint disorder (TMD) causes pain in the jaw joint and the muscles that control jaw movement. Masseter hypertrophy (enlargement of the jaw clenching muscles) often develops as a result of chronic bruxism (teeth grinding or jaw clenching).

• Clinical Definition: Injections into the masseter and temporalis muscles are performed to reduce the force of jaw clenching, thereby relieving facial pain, tension headaches, and protecting the teeth from wear.
• The Regulatory Catch: While highly effective, using Botox for TMJ or masseter hypertrophy is currently off-label (not FDA-approved for this specific indication). Because it is off-label, insurance rarely covers it, and HSA/FSA administrators audit these claims with extreme scrutiny to ensure they are not being used as a cover-up for jaw-line contouring (masseter slimming).
• Documentation Threshold: To get TMJ Botox approved, the LMN must prove that the treatment is treating a functional jaw disorder rather than shape alteration. The documentation should show that conservative therapies (custom nightguards, physical therapy, oral muscle relaxants, and NSAIDs) have failed to manage the symptoms.
• CPT Medical Coding:
  • CPT 64612: Chemodenervation of muscle(s) innervated by the facial nerve — the code most payers accept for the masseter, temporalis, and other craniofacial muscles used in TMJ treatment. (CPT 64611 is not correct here; it is defined as chemodenervation of the parotid and submandibular salivary glands for sialorrhea.)
  • ICD-10 Diagnostic Code: Must include codes such as M26.62 (Arthralgia of temporomandibular joint) or M26.69 (Other specified temporomandibular joint disorders).

---

Other Therapeutic Indications: A Comprehensive Reference Table

While chronic migraines, hyperhidrosis, and TMJ are the most common reasons patients seek FSA/HSA reimbursement for Botox, several other neurological and muscular disorders qualify under IRC Section 213(d). The table below outlines the necessary CPT codes, diagnostic codes, dosing standards, and documentation requirements for these therapeutic applications:

---

Step-by-Step Patient Workflow for Reimbursement

To ensure your therapeutic Botox treatment is fully substantiated and survives an IRS audit or a plan administrator review, follow this standardized step-by-step workflow:

Step 1: Schedule a Diagnostic Consultation

Do not begin treatment with the assumption that your provider can backdate or justify an LMN after the procedure.

• Book an evaluation specifically to discuss your clinical symptoms (migraines, sweating, jaw pain).
• Ensure the provider is a licensed MD, DO, NP, or PA. Cosmetologists or non-medical estheticians cannot diagnose clinical conditions or sign LMNs.
• Request that your medical file explicitly documents your history of symptoms, physical examinations, and any prior therapies tried.

Step 2: Draft and Sign the Letter of Medical Necessity (LMN)

• Work with your provider to complete the LMN before your injection date.
• Confirm the letter contains a specific ICD-10 diagnostic code, treatment frequency, and the provider's NPI.
• The signed date on the LMN must precede or match the date of the first Botox treatment for which you are requesting reimbursement. The IRS does not recognize retroactive LMNs.

Step 3: Verify Plan Administrator Requirements

• Log into your FSA or HSA portal or call the customer service number on your card.
• Ask if the administrator requires a specific LMN form (some providers like Optum, HealthEquity, or WageWorks have proprietary forms).
• Submit the completed LMN to your administrator's database for pre-clearance if they offer it.

Step 4: Perform the Treatment and Obtain the Itemized Invoice

On the day of your procedure:

• Verify that the clinic labels your invoice as a medical service.
• The invoice must list:
  • The patient's name and provider's name/NPI.
  • The injection procedure code (CPT code).
  • The specific drug name (e.g., "OnabotulinumtoxinA" or "Botox 100 units vial").
  • The diagnostic code (ICD-10).
  • A breakdown showing the cost of the drug and the injection procedure fee separately.

Step 5: Pay and Submit Claims

• If using an HSA, pay with your HSA card (or pay out of pocket and request a withdrawal).
• If using an FSA, pay out of pocket first, then submit a manual claim form along with the itemized invoice and the signed LMN to your administrator's portal.
• Archiving: Keep copies of the LMN, invoice, medical records, and payment receipts in a secure folder. The IRS recommends archiving these tax records for at least seven years in case of auditing.

---

Advanced HSA and FSA Audit Scenarios: Frequently Contested Cases

Even with an LMN in hand, certain clinical and financial scenarios can cause plan administrators to contest or deny your Botox reimbursement claims. Patients and providers should understand these edge cases:

Case 1: Combining Therapeutic and Cosmetic Injections

It is very common for patients to receive masseter Botox for TMJ while simultaneously requesting forehead injections to soften wrinkles.

• The Audit Risk: Plan administrators will deny the entire receipt if they spot a single charge that is non-itemized or suggests cosmetic use.
• Correct Billing: The provider must generate two separate invoices:
  1. Therapeutic Invoice: Itemizing the CPT code 64612 (masseter), diagnostic code M26.62 (TMJ), the number of units used for the jaw, and the corresponding cost. This is paid with the HSA/FSA card.
  2. Cosmetic Invoice: Listing the wrinkle treatment as a flat fee or per unit charge. This must be paid with a personal credit card or cash.
• The Syringe Dilemma: Ensure the provider's notes clearly separate the units drawn for each purpose to verify that HSA funds were not used to purchase product injected for cosmetic enhancement.

Case 2: Sourcing Botox with Manufacturer Loyalty Programs (Allē Points)

AbbVie offers the "Allē" loyalty program, allowing patients to earn points on treatments and redeem them as cash discounts.

• The Audit Risk: If you earn points on a cosmetic filler treatment and redeem a $50 discount on a therapeutic Botox session, using HSA/FSA funds for the remaining balance can be complex.
• IRS Rule: You can only use HSA/FSA funds to pay for the actual out-of-pocket cash price you paid. If your bill was $600 and you used a $100 Allē coupon, you can only claim $500 from your tax-free account. Sourcing the full $600 constitutes double-dipping and is tax-evasion.
• Points Accumulation: You cannot use HSA/FSA funds to purchase pre-paid packages or gift cards to earn points for future use. The expense is only eligible when the medical service is actually performed.

Case 3: Out-of-State Treatments and Medical Tourism

Aesthetic medical tourism is common, with patients traveling across state lines to see prominent injectors.

• The Audit Risk: State laws regulate where a physician is licensed to practice medicine. If you reside in New York but travel to California for TMJ injections, your plan administrator may require proof that the provider holds an active medical license in the state where the treatment was performed.
• Telehealth Prescriptions: If you use a telehealth service to get a prescription for hyperhidrosis Botox, the prescribing physician must be licensed in your home state to write a valid prescription and sign your LMN.

---

How to Obtain a Letter of Medical Necessity (LMN)

A Letter of Medical Necessity (LMN) is a formal letter written and signed by a licensed medical provider (MD, DO, NP, or PA) explaining why a specific treatment is medically required to treat a patient's physical condition.

Without an LMN, a plan administrator will deny any Botox claim. To ensure IRS compliance, the letter must contain specific structural elements.

LMN Checklist for Providers and Patients

A compliant LMN must include:

1. Patient Information: Full legal name, date of birth, and plan member ID.
2. Provider Information: Name, practice address, NPI number, and contact info.
3. Specific Diagnosis: A clear ICD-10 diagnostic code (e.g., G43.709 for chronic migraine, M26.62 for TMJ joint arthralgia).
4. Clinical Symptoms: Detailed symptoms demonstrating the severity of the disease and its impact on the patient's functional life.
5. Treatment History: A list of prior conservative treatments that failed (e.g., failed medications, nightguards, topical therapies).
6. Treatment Plan: The specific therapeutic recommendation, including the drug (Botox), estimated frequency (typically every 12 to 16 weeks), and duration of the treatment plan (usually 12 months).
7. IRS Declaration: A statement confirming the treatment is therapeutic and not cosmetic.
8. Provider Signature: A physical or verified digital signature with the date.

Compliant Letter of Medical Necessity Template

[Date]

Attn: HSA/FSA Plan Administrator
[Plan Provider Name]
[Plan Provider Address]

RE: Letter of Medical Necessity for OnabotulinumtoxinA (Botox) Therapy
Patient Name: [Patient Full Name]
Date of Birth: [Patient Date of Birth]
FSA/HSA Account/Member ID: [Account/Member Number]

To Whom It May Concern,

I am writing on behalf of my patient, [Patient Full Name], to document the medical necessity of OnabotulinumtoxinA (Botox) injections for the treatment of [Insert Primary Diagnosis, e.g., Chronic Migraine / Severe Primary Axillary Hyperhidrosis / Severe Temporomandibular Joint Dysfunction].

Diagnosis Details:
- Primary Diagnosis: [Insert Diagnosis Name]
- ICD-10 Code: [Insert exact ICD-10 Code, e.g., G43.709 / L74.510 / M26.62]
- Onset of Symptoms: [Date/Year symptoms began]

Clinical Indications & Functional Impairment:
The patient presents with severe clinical symptoms that significantly impair daily function. Specifically, the patient experiences [describe symptoms: e.g., severe localized jaw pain making mastication difficult, daily tension headaches, or more than 15 debilitating migraine days per month, or excessive underarm sweating requiring changes of clothing multiple times daily].

Prior Conservative Therapies Attempted & Failed:
To date, the patient has attempted conservative treatments which have failed to resolve the symptoms:
1. [Prior treatment 1, e.g., Custom occlusal splint for TMJ / Prescription antiperspirant Drysol for hyperhidrosis] - Attempted for [duration], failed due to [lack of efficacy/side effects].
2. [Prior treatment 2, e.g., Oral preventative medications like topiramate or amitriptyline for migraine] - Attempted for [duration], failed due to [lack of efficacy/intolerance].

Recommended Treatment Plan:
Based on the patient's clinical presentation and failure of conservative management, I have prescribed therapeutic OnabotulinumtoxinA (Botox) injections. The planned treatment protocol involves:
- Target Procedure: Chemodenervation of [target muscles, e.g., muscles of mastication / eccrine glands / cranial muscles]
- Expected CPT Code: [CPT Code, e.g., 64612 / 64650 / 64615]
- Dosing Interval: Injections are required every [e.g., 12 weeks / 3 months] to prevent symptom recurrence.
- Duration of Treatment: This plan of care is medically necessary for a period of [e.g., 12 months], at which point the patient's clinical response will be re-evaluated.

This treatment is not elective or cosmetic. It is prescribed solely to restore physiological function and alleviate a diagnosed, chronic medical condition. I request that you approve the reimbursement of these medical costs from the patient's FSA/HSA tax-exempt funds.

Please contact my office at [Phone Number] should you require any additional clinical records.

Sincerely,

[Provider Physical Signature]

__________________________________
[Provider Name, Credentials: MD/DO/NP/PA]
[NPI Number]
[State License Number]
[Clinic/Practice Name]
[Address, City, State, Zip]

---

Double-Dipping and Auditing Risks: What Happens If You Cheat the System?

As the popularity of masseter slimming and anti-wrinkle Botox rises, some medical spas and patients attempt to slide cosmetic treatments through FSA/HSA cards by request. Providers and patients must understand that doing so constitutes tax fraud.

How Administrators Flag Fraudulent Claims

Plan administrators utilize sophisticated software to flag transactions at aesthetic facilities. The primary indicators of a suspicious claim include:

1. Merchant Category Code (MCC) Flags: Transactions at businesses classified as beauty salons, wellness centers, or spas are audited automatically.
2. Generic Receipts: A hand-written receipt or a receipt from a point-of-sale system (like Square or Clover) that simply reads "Botox - 40 units" or "Aesthetic Services" will be rejected.
3. Missing Medical Codes: If the receipt does not contain a specific CPT procedural code and an ICD-10 diagnostic code, administrators will refuse to substantiate the transaction.
4. No Split Billing: If a patient receives cosmetic injections in the forehead and therapeutic injections in the masseter during the same visit, the provider must issue separate, itemized invoices. Swiping a tax-free card for the combined total is a direct violation of IRS rules.

The Consequences of Non-Compliance

If an FSA administrator rejects a card transaction and the patient cannot provide a valid LMN and itemized invoice within the plan's grace period:

• The FSA card will be suspended, preventing any further transactions.
• The employer may withhold the amount of the transaction from the employee's paycheck to preserve the tax status of the entire company's FSA plan.
• For HSAs, if the IRS discovers an unqualified distribution during an audit, the patient must pay standard income tax on the amount plus a 20% penalty. The physician who falsified an LMN or billing code to assist a patient in avoiding taxes can face state medical board discipline for fraudulent documentation.

---

Summary FAQ

Can my FSA/HSA card be declined at a med spa even if I have a Letter of Medical Necessity (LMN)?

Yes, your card will likely be declined at the point of sale. Most medical spas and aesthetic clinics are classified under Merchant Category Codes (MCCs) associated with beauty or cosmetic services. Payment networks automatically block FSA/HSA cards at these locations to prevent unqualified spending. If this happens, you must pay for the procedure using a personal credit card or cash, obtain an itemized receipt containing CPT and ICD-10 codes, and submit a manual reimbursement claim along with your signed LMN to your plan administrator.

What happens if I use my HSA card for cosmetic Botox and get audited?

If the IRS audits your tax return and discovers that you used tax-free HSA funds for a non-qualified cosmetic expense (such as wrinkle reduction), the amount of the distribution will be added to your taxable income for that year. You will be required to pay the back taxes owed on that income plus a 20% IRS penalty for non-qualified distributions. Keep all receipts and Letters of Medical Necessity for at least seven years to substantiate your tax-free medical expenses under audit.

---

Sources

• Internal Revenue Service. Publication 502 (2025), Medical and Dental Expenses. Available at: https://www.irs.gov/publications/p502
• Internal Revenue Code. Section 213(d) (26 U.S.C. § 213(d)) — Medical, dental, and cosmetic expenses.
• U.S. Food and Drug Administration. Drugs@FDA Database: OnabotulinumtoxinA (BLA 103000). Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000
• FSAFEDS. Eligible Expenses Database: Botox Treatments. Available at: https://www.fsafeds.gov/explore/hcfsa/expenses?q=botox
• American Academy of Neurology. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012;78(17):1337-1345.
• American Society of Plastic Surgeons. Botulinum Toxin (Botox) Cost Planning. Available at: https://www.plasticsurgery.org/cosmetic-procedures/botulinum-toxin/cost
• Internal Revenue Service. Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans. Available at: https://www.irs.gov/publications/p969